1. Analysis of redox status and HDL subclasses in patients with lymphoma and the associations with FDG-PET/CT findings
- Author
-
Bosa Mirjanic-Azaric, Sinisa Stankovic, Lana Nezic, Zana Radic Savic, Dragana Malcic- Zanic, Ranko Skrbic, Jelena Kotur-Stevuljevic, and Natasa Bogavac-Stanojevic
- Subjects
redox status ,HDL subclasses ,SUVmax ,Hodgkin lymphoma ,non-Hodgkin lymphoma ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Newer research points to alterations in the plasma redox status and the HDL subclass distributions in cancer. We aimed to assess the redox status and the HDL subclass distributions, lipids, and inflammatory markers in lymphoma patients in order to determine whether they were correlated with changes in FDG-PET/CT scans. At the beginning of this study, redox status, HDL subclasses, lipids, and inflammation biomarkers were determined in 58 patients with lymphoma (Hodgkin lymphoma, n=11 and non-Hodgkin lymphoma, n=47), and these same measurements were reassessed during their ensuing treatment (in 25 patients). Initially, the total oxidation status (TOS), the prooxidant–antioxidant balance (PAB), the OS index (OSI), the total protein sulfhydryl groups (SH-groups), and the advanced oxidation protein products (AOPP) were significantly higher in lymphoma patients as compared to healthy subjects, but the total antioxidant status (TAS) was significantly reduced. The PAB had a strong correlation with the CRP and interleukin-6 (rho=0.726, p
- Published
- 2023
- Full Text
- View/download PDF